BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2257558)

  • 1. Hematopoietic growth factors in oncology.
    Mertelsmann R; Lindemann A; Oster W; Gamm H; Kolbe K; Herrmann F
    Cancer Detect Prev; 1990; 14(6):613-6. PubMed ID: 2257558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current status of clinical indications for hematopoietic growth factors after chemo-/radiotherapy in gynecology].
    Karthaus M; Ganser A
    Zentralbl Gynakol; 1997; 119(12):585-96. PubMed ID: 9483809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hematopoietic growth factors in transfusion medicine.
    Whitsett CF
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of hematopoietic growth factors--general principles].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1996; 49(5-6):185-93. PubMed ID: 8692093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-3 in hematology and oncology: current state of knowledge and future directions.
    Mangi MH; Newland AC
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid hemopoietic growth factors. Review article.
    Vrhovac R; Kusec R; Jaksić B
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):241-52. PubMed ID: 8314653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors.
    Williams ME; Quesenberry PJ
    Hematol Pathol; 1992; 6(3):105-24. PubMed ID: 1429340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of flt3 ligand on in vitro growth and expansion of colony-forming bone marrow cells from patients with aplastic anemia.
    Wodnar-Filipowicz A; Chklovskaia E; Manz CY; Lyman SD; Nissen C
    Exp Hematol; 1997 Jul; 25(7):573-81. PubMed ID: 9216732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood.
    Van Zant G; Rummel SA; Koller MR; Larson DB; Drubachevsky I; Palsson M; Emerson SG
    Blood Cells; 1994; 20(2-3):482-90; discussion 491. PubMed ID: 7538353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic growth factors for the treatment of inherited cytopenias.
    Zeidler C; Welte K
    Semin Hematol; 2007 Jul; 44(3):133-7. PubMed ID: 17631177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hematopoietic growth factors].
    Zwierzina H; Hoffmann S; Schmalzl F; Braunsteiner H
    Wien Med Wochenschr; 1991; 141(14):311-20. PubMed ID: 1949830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.